Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced today the results of the Phase 3 PALISADE study evaluating investigational plozasiran in patients with familial chylomicronemia syndrome (FCS), a rare and severe genetic…
CVS Pharmacy® (NYSE: CVS) has announced that the updated 2024-2025 flu and COVID-19 vaccines are now available at CVS Pharmacy and MinuteClinic® locations nationwide. Patients can walk in for a…
Noetik, an AI-driven biotech firm using self-supervised machine learning and high-throughput spatial data to create cutting-edge cancer therapies, has announced the successful closure of an oversubscribed $40 million Series A…
Renata Medical has announced that the U.S. Food and Drug Administration (FDA) has approved its innovative Minima Growth Stent, designed specifically for neonates, infants, and young children. This unique stent…
RebrAIn, a leader in precision neuro-surgery platforms, has secured its second FDA 510(k) clearance for its OptimMRI software. The latest version includes a machine learning model designed to aid in…
Novotech, a global full-service clinical Contract Research Organization (CRO), is pleased to announce its renewal as a Workplace Gender Equality Agency (WGEA) Employer of Choice for Gender Equality (EOCGE) for…
Statistics & Data Corporation (SDC), a leader in life sciences biometrics and technology solutions, has introduced its innovative Bring Your Own Device (BYOD) electronic Patient Reported Outcomes (ePRO) solution. This…
Repare Therapeutics Inc. (Nasdaq: RPTX), a clinical-stage precision oncology company, announced a strategic shift to prioritize the development of its clinical-stage oncology programs. The company will concentrate on advancing its…
Fresenius Kabi has introduced Cetrorelix Acetate for Injection, an FDA-approved, cost-effective generic option for women’s reproductive health. The kit, available immediately, includes one single-dose vial of 0.25 mg cetrorelix, a…
BioAesthetics Corporation has appointed Dr. Juliana Blum, PhD, as its new Chief Executive Officer, starting August 12, 2024. Dr. Sandra Coufal, MD, Director of BioAesthetics and CEO of Toragen, Inc.,…
Qventus, a leader in AI-driven care operations software, has introduced the industry’s first AI Operational Assistants. These innovative digital assistants are designed to help frontline staff focus on their core…
ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: IPA) is excited to announce its participation in the 26th Annual HC Wainwright Global Investment Conference. The conference, held in-person at the Lotte New York…
